Professional guideline versus product label selection for treatment with IV thrombolysis: an analysis from SITS registry
Thrombolysis usage in ischaemic stroke varies across sites. Divergent advice from professional guidelines and product labels may contribute. Patients and methods: We analysed SITS-International registry patients enrolled January 2010 through June 2016. We grouped sites into organisational tertiles b...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2017 Dec 8
|
| In: |
European stroke journal
Year: 2017, Volume: 3, Issue: 1, Pages: 39-46 |
| ISSN: | 2396-9881 |
| DOI: | 10.1177/2396987317747737 |
| Online Access: | Verlag: http://dx.doi.org/10.1177/2396987317747737 Verlag: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453242/ 
|
| Author Notes: | Alan C Cameron, James Bogie, Azmil H Abdul-Rahim, Niaz Ahmed, Michael Mazya, Robert Mikulik, Werner Hacke and Kennedy R Lees; or the SafeImplementation of Treatments in Stroke (SITS) Investigators |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1679444476 | ||
| 003 | DE-627 | ||
| 005 | 20220817005558.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191023r20182017xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/2396987317747737 |2 doi | |
| 035 | |a (DE-627)1679444476 | ||
| 035 | |a (DE-599)KXP1679444476 | ||
| 035 | |a (OCoLC)1341249095 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Cameron, Alan |e VerfasserIn |0 (DE-588)1197711864 |0 (DE-627)1679444794 |4 aut | |
| 245 | 1 | 0 | |a Professional guideline versus product label selection for treatment with IV thrombolysis |b an analysis from SITS registry |c Alan C Cameron, James Bogie, Azmil H Abdul-Rahim, Niaz Ahmed, Michael Mazya, Robert Mikulik, Werner Hacke and Kennedy R Lees; or the SafeImplementation of Treatments in Stroke (SITS) Investigators |
| 264 | 1 | |c 2017 Dec 8 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 23.10.2019 | ||
| 520 | |a Thrombolysis usage in ischaemic stroke varies across sites. Divergent advice from professional guidelines and product labels may contribute. Patients and methods: We analysed SITS-International registry patients enrolled January 2010 through June 2016. We grouped sites into organisational tertiles by number of patients arriving ≤2.5 h and treated ≤3 h, percentage arriving ≤2.5 h and treated ≤3 h, and numbers treated ≤3 h. We assigned scores of 1-3 (lower/middle/upper) per variable and 2 for onsite thrombectomy. We classified sites as lower efficiency (summed scores 3-5), medium efficiency (6-8) or higher efficiency (9-11). Sites were also grouped by adherence with European product label and ESO guideline: ‘label adherent’ (>95% on-label), ‘guideline adherent’ (≥5% off-label, ≥95% on-guideline) or ‘guideline non-adherent’ (>5% off-guideline). We cross-tabulated site-efficiency and adherence. We estimated the potential benefit of universally selecting by ESO guidance, using onset-to-treatment time-specific numbers needed to treat for day 90 mRS 0-1. Results: A total of 56,689 patients at 597 sites were included: 163 sites were higher efficiency, 204 medium efficiency and 230 lower efficiency. Fifty-six sites were ‘label adherent’, 204 ‘guideline adherent’ and 337 ‘guideline non-adherent’. There were strong associations between site-efficiency and adherence (P < 0.001). Almost all ‘label adherent’ sites (55, 98%) were lower efficiency. If all patients were treated by ESO guidelines, an additional 17,031 would receive alteplase, which translates into 1922 more patients with favourable three-month outcomes. Discussion: Adherence with product labels is highest in lower efficiency sites. Closer alignment with professional guidelines would increase patients treated and favourable outcomes. Conclusion: Product labels should be revised to allow treatment of patients ≤4.5 h from onset and aged ≥80 years. | ||
| 534 | |c 2017 | ||
| 700 | 1 | |a Bogie, James |e VerfasserIn |4 aut | |
| 700 | 1 | |a Abdul-Rahim, Azmil H |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ahmed, Niaz |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mazya, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mikulik, Robert |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hacke, Werner |d 1948- |e VerfasserIn |0 (DE-588)12021699X |0 (DE-627)080530346 |0 (DE-576)164358854 |4 aut | |
| 700 | 1 | |a Lees, Kennedy R |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European stroke journal |d London : Sage Publishing, 2016 |g 3(2018), 1, Seite 39-46 |h Online-Ressource |w (DE-627)856122106 |w (DE-600)2851287-X |w (DE-576)462988643 |x 2396-9881 |7 nnas |a Professional guideline versus product label selection for treatment with IV thrombolysis an analysis from SITS registry |
| 773 | 1 | 8 | |g volume:3 |g year:2018 |g number:1 |g pages:39-46 |g extent:8 |a Professional guideline versus product label selection for treatment with IV thrombolysis an analysis from SITS registry |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/2396987317747737 |x Verlag |x Resolving-System |
| 856 | 4 | 0 | |u https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453242/ |x Verlag |
| 951 | |a AR | ||
| 992 | |a 20191023 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 12021699X |a Hacke, Werner |m 12021699X:Hacke, Werner |d 50000 |e 50000PH12021699X |k 0/50000/ |p 7 | ||
| 999 | |a KXP-PPN1679444476 |e 3526315949 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 23.10.2019"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"id":{"zdb":["2851287-X"],"eki":["856122106"],"issn":["2396-9881"]},"name":{"displayForm":["European Stroke Organisation (ESO)"]},"language":["eng"],"part":{"issue":"1","volume":"3","pages":"39-46","text":"3(2018), 1, Seite 39-46","extent":"8","year":"2018"},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Professional guideline versus product label selection for treatment with IV thrombolysis an analysis from SITS registryEuropean stroke journal","recId":"856122106","title":[{"title_sort":"European stroke journal","title":"European stroke journal","subtitle":"ESJ"}],"origin":[{"publisherPlace":"London","dateIssuedDisp":"[2016]-","publisher":"Sage Publishing"}],"titleAlt":[{"title":"ESJ"}],"note":["Gesehen am 10.04.2024","Fortsetzung der Druck-Ausgabe"],"pubHistory":["Volume 1, issue 1 (March 2016)-"],"type":{"bibl":"periodical","media":"Online-Ressource"}}],"title":[{"title":"Professional guideline versus product label selection for treatment with IV thrombolysis","title_sort":"Professional guideline versus product label selection for treatment with IV thrombolysis","subtitle":"an analysis from SITS registry"}],"person":[{"given":"Alan","family":"Cameron","role":"aut","display":"Cameron, Alan"},{"family":"Bogie","display":"Bogie, James","role":"aut","given":"James"},{"display":"Abdul-Rahim, Azmil H","role":"aut","family":"Abdul-Rahim","given":"Azmil H"},{"given":"Niaz","family":"Ahmed","role":"aut","display":"Ahmed, Niaz"},{"given":"Michael","role":"aut","display":"Mazya, Michael","family":"Mazya"},{"role":"aut","display":"Mikulik, Robert","family":"Mikulik","given":"Robert"},{"family":"Hacke","role":"aut","display":"Hacke, Werner","given":"Werner"},{"given":"Kennedy R","family":"Lees","display":"Lees, Kennedy R","role":"aut"}],"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"2017 Dec 8"}],"id":{"eki":["1679444476"],"doi":["10.1177/2396987317747737"]},"name":{"displayForm":["Alan C Cameron, James Bogie, Azmil H Abdul-Rahim, Niaz Ahmed, Michael Mazya, Robert Mikulik, Werner Hacke and Kennedy R Lees; or the SafeImplementation of Treatments in Stroke (SITS) Investigators"]},"physDesc":[{"extent":"8 S."}],"language":["eng"],"recId":"1679444476"} | ||
| SRT | |a CAMERONALAPROFESSION2017 | ||